Cite

HARVARD Citation

    Correll, C. et al. (2021). Safety and Effectiveness of SEP−363856 in Schizophrenia: Results of a 6-Month, Open-Label Extension Study. CNS spectrums. pp. 148-149. [Online]. 
  
Back to record